Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists. ...
Source:
St. Joseph's Hospital and Medical Center
Tuesday, February 9, 2010